Welcome to LookChem.com Sign In|Join Free

CAS

  • or
1-tert-butyl 2-methyl (2S,4S)-4-({4-[(3-chloro-2-fluorophenyl)amino]-7-methoxyquinazolin-6-yl}oxy)piperidine-1,2-dicarboxylate is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

908294-09-7

Post Buying Request

908294-09-7 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 1-tert-butyl 2-methyl (2S,4S)-4-({4-[(3-chloro-2-fluorophenyl)amino]-7-methoxyquinazolin-6-yl}oxy)piperidine-1,2-dicarboxylate

    Cas No: 908294-09-7

  • Need to discuss

  • No requirement

  • Adequate

  • Hubei Vanz Pharm Co.,Ltd
  • Contact Supplier
  • 1-tert-butyl 2-methyl (2S,4S)-4-({4-[(3-chloro-2-fluorophenyl)amino]-7-methoxyquinazolin-6-yl}oxy)piperidine-1,2-dicarboxylate

    Cas No: 908294-09-7

  • Need to discuss

  • No requirement

  • Adequate

  • Shanghai Surseechem Co.,Ltd.
  • Contact Supplier

908294-09-7 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 908294-09-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,0,8,2,9 and 4 respectively; the second part has 2 digits, 0 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 908294-09:
(8*9)+(7*0)+(6*8)+(5*2)+(4*9)+(3*4)+(2*0)+(1*9)=187
187 % 10 = 7
So 908294-09-7 is a valid CAS Registry Number.

908294-09-7Relevant articles and documents

QUINAZOLINE DERIVATIVES AS TYROSINE KINASE INHIBITORS

-

Page/Page column 67-69, (2008/06/13)

The invention concerns quinazoline derivatives of the Formula (I), or pharmaceutically acceptable salts thereof: I wherein each of R1, R2, R3, R4 and m are as defined in the description; processes for their preparation; pharmaceutical compositions containing them and their use in the manufacture of a medicament for providing an anti-proliferative effect. The quinazoline derivatives of Formula (I) are expected to be useful in the treatment of diseases such as certain cancers mediated by erbB receptor tyrosine kinases, particularly EGFR tyrosine kinase.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 908294-09-7